Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

Clinical trial NCT05747924 · COMPLETED

Trial details

NCT number: NCT05747924
Sponsor: Avidity Biosciences, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

FSHD FSHD1 FSHD2 FMD FMD2 Fascioscapulohumeral Muscular Dystrophy Fascioscapulohumeral Muscular Dystrophy Type 1 Fascioscapulohumeral Muscular Dystrophy Type 2 Dystrophies, Facioscapulohumeral Muscular Dystrophy, Facioscapulohumeral Muscular Facioscapulohumeral Muscular Dystrophy 1 Facioscapulohumeral Muscular Dystrophy 2

Start date: 2023-04-04
Primary completion: 2026-03-18
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.